Comments to amendment of instructions of BCG vaccine for intradermal injection

doi:10.3969/j.issn.1000-6621.2014.10.001

Abstract

ZHAO Ai-hua, KOU Li-jie, XU Miao, WANG Guo-zhi. Comments to amendment of instructions of BCG vaccine for intradermal injection[J]. Chinese Journal of Antituberculosis, 2014, 36(10): 863-867. doi: 10.3969/j.issn.1000-6621.2014.10.001

References

［1］国家药典委员会. 中国人民共和国药典2010年版.三部. 北京：中国医药科技出版社，2011：81-82.
［2］中华人民共和国卫生部. 预防接种工作规范. 2005-09-20.
［3］World Health Organization. BCG vaccine. WHO position paper. Wkly Epidemiol Rec，2004，79(4): 27-38.
［4］卢水华，李涛，席秀红，等. 播散性卡介菌病23例分析. 中华传染病杂志，2013，31(7): 417-421.
［5］徐尔迪，陈玺，肖延风. 联合免疫缺陷病引起卡介苗接种后死亡1例及文献复习. 中国儿童保健杂志，2012，20(8): 767-768.
［6］李奕新，章国平，田建三，等. 细胞免疫缺陷致全身播散性卡介苗感染死亡1例. 中国防痨杂志，2008，30(5): 489-490.
［7］黄启功. 对8例婴儿接种卡介苗播散性疾病患者的报道. 求医问药，2011，9(9): 244-245.
［8］Hu Y，Zhao Q，Wu L，et al. Prevalence of latent tuberculosis infection and its risk factors in schoolchildren and adolescents in Shanghai, China. Eur J Public Health，2013，23(6): 1064-1069.
［9］李克莉，刘大卫，武文娣，等. 2009—2010年全国卡介苗疑似预防接种异常反应监测分析. 中国疫苗和免疫，2012，18(3): 252-260.
［10］彭晓雯，刘大卫. 卡介苗预防接种安全性综述. 中国疫苗和免疫，2010，16(6): 558-563.
［11］武文娣，刘大卫，李黎，等. 2000—2007年卡介苗疑似预防接种异常反应文献分析. 中国疫苗和免疫，2009，15(6): 491-495.
［12］World Health Organization. Global Tuberculosis Report 2013［EB/OL］. Geneva: World Health Organization，2014.
［13］王临虹. 预防艾滋病母婴传播.北京：人民出版社，2000.
［14］Hesseling AC，Marais BJ，Gie RP，et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine，2007，25(1): 14-18.
［15］Hesseling AC，Johnson LF，Jaspan H，et al. Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants. Bull World Health Organ，2009，87(7): 505-511.
［16］World Health Organization. Recommendations to assure the Quality, safety and efficacy of BCG vaccines. Geneva: World Health Organization, 2013.
［17］Revised BCG vaccination guidelines for infants at risk for HIV infection. Wkly Epidemiol Rec，2007，82(21): 193-196.
［18］Global Advisory Committee on Vaccine Safety,3-4 December 2009. Wkly Epidemiol Rec，2010，85(5): 29-33.
［19］余晓峰，齐娜，仓决卓玛. 接种卡介苗后有无卡痕者的PPD阳转率调查. 中国计划免疫，1995，1(2): 43.
［20］胡京坤. 新生儿接种卡介苗后卡痕与结核菌素反应之关系. 中国防痨杂志，2010，32(8): 475-476.

[1]	CHEN Ning, SUN Lin, SHEN A-dong, HE Qiu-shui. Possible causes of infection after BCG vaccination [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 869-873.
[2]	ZHAO Ai-hua, KANG Wan-li, WANG Guo-zhi, GAO Zheng-lun, DU Wei-xin, LU Jin-biao, SHEN Xiao-bing, SU Cheng, XU Miao, ZHENG Su-hua. Screening for latent tuberculosis infection and identification of BCG vaccination by recombinant Mycobacterium tuberculosis 11 kDa [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 821-825.
[3]	CHEN Ning, SUN Lin, SHEN A-dong, HE Qiu-shui. Research progress on the non-specific protective effect of BCG [J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1128-1133.
[4]	Ai-hua ZHAO,Guo-zhi WANG,Li-li FU,Miao. XU. Comparison of BCG vaccine quality standards of domestic and foreign [J]. Chinese Journal of Antituberculosis, 2018, 40(10): 1125-1128.
[5]	MENG Wei-li, LUO Ping, HU Jing-kun, SUN Zhao, LI Hui-ying, LIAN He-yu. Results analysis of TB screening among university students using BCG-PPD and TB-PPD [J]. Chinese Journal of Antituberculosis, 2014, 36(7): 542-546.
[6]	HUANG Xiang-yu, ZHANG Chun-qing, LI Jun-li, SHAO Jin-shi, HE Xiu-yun. MF59 adjuvant enhances immunogenicity of heat-killed BCG [J]. Chinese Journal of Antituberculosis, 2014, 36(6): 440-446.
[7]	LAI Sai-lin，SUN Yi-fan，CHEN Tao，YANG Xiao， ZHOU Lin，ZHONG Qiu. Experimental study on killing fluorescent M. bovis BCG by IFN-γ activated THP-1 derived macrophages [J]. Chinese Journal of Antituberculosis, 2014, 36(5): 362-368.
[8]	KANG Wan-li, LING Ying, XU Miao, ZHAO Ai-hua, DU Wei-xin, CHEN Ming, GAO Tie-jie, ZHANG Zhi-guo, HU Dai-yu, FENG Xian-hui, GUO Jing, ZHANG Hai-xia, HE Ju, LIU Guan, LI Hai-ying, WU Xin-yue, WANG Cui-z. Study on the efficacy of BCG vaccine for intradermal injection [J]. Chinese Journal of Antituberculosis, 2014, 36(4): 248-252.
[9]	LU Jin-biao, ZHAO Ai-hua, WANG Guo-zhi, XU Miao. Discussion on the immunoprophylaxis strategy of tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2014, 36(11): 927-929.
[10]	. The research progression of tuberculosis vaccine on antigen85 complex [J]. Chinese Journal of Antituberculosis, 2013, 35(4): 282-285.
[11]	CHEN Bao-wen，SHEN Xiao-bing，DU Wei-xin，SU Cheng，YANG Lei，LU Jin-biao，WANG Guo-zhi. Development of BCG reference system of evaluating the protective efficacy of vaccine in China [J]. Chinese Journal of Antituberculosis, 2012, 34(3): 150-153.
[12]	WU Wen-qing，LI Bo，NI Xin-lan，AN Yan-sheng. Clinic and curative effect analysis on 112 cases with strong reactions of lymph node caused by neonatal BCG vaccination [J]. Chinese Journal of Antituberculosis, 2012, 34(04): 241-244.